Dabigatran-induced chronic progressive immune hemolytic anemia: A case report

We present a case of immune hemolytic anemia (IHA) due to dabigatran use in a 72-year-old male with NVAF.

Source: Journal of Stroke and Cerebrovascular Diseases - July 15, 2020 Category: Neurology Authors: Jin-Hong Gong, Guang-Jun Liu, Feng Zhou, Zhi-Qiang Sun Tags: Case Report Source Type: research